You are here
IMMUSOFT CORP
UEI: N6KEM57XYJB7
# of Employees: 8
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Transposon Engineered B Cell Therapy for Hunter Syndrome
Amount: $466,804.00PROJECT SUMMARY Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is an X-linked recessive lysosomal disease caused by the absence of iduronate-2-sulfatase (IDS), resulting in systemic accumulat ...
SBIRPhase I2020Department of Health and Human Services National Institutes of Health -
Sleeping Beauty Engineered B Cells for Mucopolysaccharidosis
Amount: $3,589,215.00Project Summary Mucopolysaccharidosis type IMPS Iis an autosomal recessive storage disease caused by the absence ofL iduronidaseIDUAresulting in systemic accumulation of glycosaminoglycanGAGstorage ma ...
SBIRPhase II2018Department of Health and Human Services National Institutes of Health -
Testing of novel system to deliver VRC01 in mouse model
Amount: $300,000.00DESCRIPTION (provided by applicant): HIV/AIDS is a global epidemic afflicting more than 33 million people worldwide. HIV can often be suppressed for many years with anti-retroviral medications, and ov ...
STTRPhase I2012Department of Health and Human Services National Institutes of Health
